Kyntra Bio KYNB
NASDAQ KYNB
$3.20 -0.29 (-8.31%)
At close: Nov 16, 2026 · 4:00 PM EST

Kyntra Bio (KYNB) Gains from Sales and Divestitures (2014 - 2026)

Updated

Kyntra Bio (KYNB) recorded Gains from Sales and Divestitures of -$66,000 in Q1 2026.

Analysis

Kyntra Bio (KYNB) Gains from Sales and Divestitures (2014 - 2026) Analysis & Trends

For FY2025, Kyntra Bio reported Gains from Sales and Divestitures of $52.55 million.

  • Across earlier years, Gains from Sales and Divestitures came in at -$2.55 million in FY2024, -$4,000 in FY2023, $1,000 in FY2022 and -$233,000 in FY2021.
  • The Q1 2026 figure is the lowest quarterly Gains from Sales and Divestitures since Q4 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn
5 Novartis Ag 310.90 Bn 284.14 Bn -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn
10 Kyntra Bio 12.57 Mn -395.37 Mn 1.47 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -66,000.00
Dec 31, 2025 390,000.00
Sep 30, 2025 52.16 Mn
Dec 31, 2024 -106,000.00
Sep 30, 2024 -2.14 Mn
Jun 30, 2024 -306,000.00
Dec 31, 2023 -3,000.00
Mar 31, 2023 -1,000.00
Dec 31, 2022 -2,000.00
Sep 30, 2022 2,000.00
Jun 30, 2022 6,000.00
Mar 31, 2022 -5,000.00
Dec 31, 2021 -1,000.00
Sep 30, 2021 -219,000.00
Jun 30, 2021 -13,000.00
Dec 31, 2020 -936,000.00
Sep 30, 2020 3,000.00
Dec 31, 2019 32,000.00
Mar 31, 2019 10,000.00
Jun 30, 2018 -53,000.00
API Access

Kyntra Bio Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=KYNB&period=max&api_key=YOUR_API_KEY